IDIQ parent award for drug manufacturing and formulatiion program (dmfp) - amri

Ended Awarded Last action

Contract number
HHSN271201500005I
Awardee
Awarding agency
Task orders
13 $12,879,554 obligated

Award facts

Opportunity
Combined order value
  • $12,879,554 Current, with exercised options
  • $16,302,773 Potential, with all options
Last date to order 100% complete
IDV ceiling 34% used
$37,393,571.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $37,393,571 to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The IDC, titled the "Drug Manufacturing and Formulation Program (DMFP)," provides a broad range of pharmaceutical research and development services to NINDS and other NIH institutes, including medicinal chemistry, chemical development, analytical testing, formulation development, and Good Manufacturing Practices (GMP) production.

The task orders issued under this IDC, which do not have any set-aside designations, task Curia with supporting NINDS initiatives across therapeutic areas such as neurology, infectious diseases, and substance abuse. Services to be provided include feasibility studies, clinical trial readiness activities, GMP/clinical trial materials production, exploratory and hit-to-lead chemistry, process chemistry, scale-up synthesis, and stability testing. The task orders have a total ceiling value of over $13 million and performance periods ranging from 2022 to 2030. This IDC award demonstrates Curia's extensive experience supporting the federal government's pharmaceutical research and development needs through prime and subcontract awards.

Task orders

Task order Ordering agency Obligated Awarded
Florio BPN project BPN-36938 75N95024F00001 National Institute on Drug Abuse (NIH) $2,502,592
Katritch- university of southern california dmfp for BPN-35269 - curia global, INC. 75N95023F00001 National Institute on Drug Abuse (NIH) $2,451,019
Feasibility studies, clinical trial readiness, GMP/clinical trial materials 75N95022F00001 National Institute on Drug Abuse (NIH) $1,135,800
Albany molecular research INC:1106422 [20-006949] 75N95020F00001 National Institute on Drug Abuse (NIH) $142,807
Albany molecular research INC - rosenzweig 75N95019F00090 National Institute on Drug Abuse (NIH) $1,022,104
Albany molecular research INC - bozik BPN 25203 75N95019F00089 National Institute on Drug Abuse (NIH) $1,771,111
Albany molecular research, INC: wagner ucsd-0776890 ICH stability study. Dmfp. 75N95019F00088 National Institute on Drug Abuse (NIH) $71,866
Dmfp task order no. 6 kenny BPN 19302 HHSN27100006 National Institute on Drug Abuse (NIH) $214,668
Dmfp task order no. 5 buckpitt BPN 19186 HHSN27100005 National Institute on Drug Abuse (NIH) $1,191,883
Dmfp - task order no. 4 wagner BPN-15606 HHSN27100004 National Institute on Drug Abuse (NIH) $51,267
Dmfp - task order no. 3 gurney BPN-14770 HHSN27100003 National Institute on Drug Abuse (NIH) $725,724
Dmfp - task order no. 2 petrukhin BPN-14967 HHSN27100002 National Institute on Drug Abuse (NIH) $1,325,649
Drug manufacturing and formulation program (dmfp) task order #01: performance activity 1 technical support (1/15/15 /… HHSN27100001 National Institute on Drug Abuse (NIH) $273,065
Show all 13

Transactions

Action Obligated Date
Other Administrative Action P00014 · Drug manufacturing and formulation program (dmfp)- change program manager (key person) $0
Other Administrative Action P00013 $0
Other Administrative Action P00012 · Drug manufacturing and formulation program (dmfp) $0
Supplemental Agreement for work within scope P00011 · Curia $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 · Albany molecular research INC - $0
Other Administrative Action 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0
Show all 15

Quick answers

Who was awarded contract HHSN271201500005I?

HHSN271201500005I was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 15, 2015.

How much is contract HHSN271201500005I worth?

Orders under HHSN271201500005I have obligated $12,879,554. Their combined potential value, with all options, is $16,302,773. HHSN271201500005I's own ceiling is $37,393,571.

How many orders have been placed under contract HHSN271201500005I?

13 orders have been placed under HHSN271201500005I, the latest on September 17, 2024.

Who can order from contract HHSN271201500005I?

HHSN271201500005I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201500005I part of a contract vehicle?

Yes. HHSN271201500005I is part of Drug Manufacturing and Formulation Program (DMFP).

Was contract HHSN271201500005I competed?

The extent of competition for HHSN271201500005I was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login